Skip to content
10-Q

Quarterly Report

REPROS THERAPEUTICS INC.

0001144204-17-043168

← back to feed
Filed
Aug 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 7, 2017 37.62M sh
Shares Diluted Q2 2017 · Jun 30, 2017 28.4M sh
Shares Diluted Q2 2017 · Jun 30, 2017 27.34M sh
Shares Diluted Q2 2017 · Jun 30, 2016 24.32M sh
Shares Diluted Q2 2017 · Jun 30, 2016 24.32M sh
Capex Q2 2017 · Jun 30, 2017 $0
Capex Q2 2017 · Jun 30, 2016 $0
Operating Cash Flow Q2 2017 · Jun 30, 2017 −$6.6M
Operating Cash Flow Q2 2017 · Jun 30, 2016 −$8.88M
Cash And Equivalents Q2 2017 · Jun 30, 2017 $3.77M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $8.69M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $12.51M
Stockholders Equity Q2 2017 · Jun 30, 2017 −$309K
Stockholders Equity Q2 2017 · Dec 31, 2016 $6.1M
Stockholders Equity Q2 2017 · Jun 30, 2016 $10.48M
Stockholders Equity Q2 2017 · Dec 31, 2015 $18.57M
Current Liabilities Q2 2017 · Jun 30, 2017 $2.73M
Current Liabilities Q2 2017 · Dec 31, 2016 $2.66M
Total Liabilities Q2 2017 · Jun 30, 2017 $6.18M
Total Liabilities Q2 2017 · Dec 31, 2016 $2.66M
Current Assets Q2 2017 · Jun 30, 2017 $4.95M
Current Assets Q2 2017 · Dec 31, 2016 $8.75M
Total Assets Q2 2017 · Jun 30, 2017 $5.87M
Total Assets Q2 2017 · Dec 31, 2016 $8.76M
Sga Expense Q2 2017 · Jun 30, 2017 $906K
Sga Expense Q2 2017 · Jun 30, 2017 $4.75M
Sga Expense Q2 2017 · Jun 30, 2016 $1.05M
Sga Expense Q2 2017 · Jun 30, 2016 $2.15M
Rd Expense Q2 2017 · Jun 30, 2017 $1.14M
Rd Expense Q2 2017 · Jun 30, 2017 $3.21M
Rd Expense Q2 2017 · Jun 30, 2016 $3.24M
Rd Expense Q2 2017 · Jun 30, 2016 $7.01M
Net Income Q2 2017 · Jun 30, 2017 −$2.2M
Net Income Q2 2017 · Jun 30, 2017 −$8.11M
Net Income Q2 2017 · Jun 30, 2016 −$4.28M
Net Income Q2 2017 · Jun 30, 2016 −$9.13M
Revenue Q2 2017 · Jun 30, 2017 $7K
Revenue Q2 2017 · Jun 30, 2017 $14K
Revenue Q2 2017 · Jun 30, 2016 $15K
Revenue Q2 2017 · Jun 30, 2016 $31K